Streetbeat News

Stock Prices

TNDM

In the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) received 1 bullish, 3 indifferent, and 1 somewhat bearish analyst rating. The average price target is $40.2, compared to the current price of $24.25, implying an upside. The average price target has decreased by 12.13% from the previous average of $45.75.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:02 pm

PACB

Over the past 3 months, 6 analysts have published their opinion on Pacific Biosciences (NASDAQ:PACB) stock, with an average 12-month price target of $14.67. The average price target has increased by 14.61% over the past month.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:01 pm

T

In the last quarter, AT&T (NYSE:T) received 3 bullish, 1 somewhat bullish, and 3 indifferent ratings from analysts. The average 12-month price target for AT&T is $21.43, a 2.59% decrease from the previous average of $22.00.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:00 pm

FAST

Fastenal (NASDAQ:FAST) has outperformed the market over the past 20 years, producing an average annual return of 13.43%. A $1000 investment in FAST stock 20 years ago would be worth $12,548.09 today.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:00 pm

GENI

Genius Sports (NYSE:GENI) has received 6 bullish and 4 somewhat bullish ratings from analysts in the last quarter. The average price target is $7.3, implying an upside from the current price of $6.31. The previous average price target was $8.00.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:00 pm

EQIX

Equinix (NASDAQ:EQIX) has produced an average annual return of 25.13% over the past 20 years, outperforming the market by 17.63% on an annualized basis. A $100 investment in EQIX 20 years ago would be worth $8,965.24 today.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 9:00 pm

MASI

Politan Capital Management, a 9% shareholder of Masimo, commented on the company's recent announcement to expand its Board and add Politan nominee Michelle Brennan, contingent on the reelection of all incumbent Masimo directors at the upcoming Annual Meeting of Stockholders.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 8:54 pm

CLS

Celestica announced that its controlling shareholder, Onex Corporation, plans to sell 12,000,000 subordinate voting shares, which will be issued upon conversion of Celestica's multiple voting shares into SVS. Celestica is not selling any shares and will not receive any proceeds from the offering.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 8:48 pm

NOW

Unusual options activity has been observed for ServiceNow (NYSE:NOW), with a bearish stance taken by a large investor. Benzinga's options scanner spotted 21 uncommon options trades, with 76% being bearish and 23% bullish. Whales have been targeting a price range of $460 to $600 for ServiceNow over the last 3 months.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 8:47 pm

KLAC

A whale has taken a bearish stance on KLA (NASDAQ:KLAC) with 63% of detected unusual options trades being bearish. 11 puts amounting to $486,652 and 8 calls amounting to $272,690 were spotted. The price target range for KLA over the last 3 months is $200 to $560. Wells Fargo maintains an Overweight rating with a $500 price target, while UBS maintains a Neutral rating with a $475 price target.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 8:46 pm